Pfizer Inc.

Recent Events

News & Analysis

pfizer inc. and sales - All News and Analysis

• J&J CEO Rubs Pfizer's Face in Disastrous Consumer Products Sale of '06

  BNET - 2009-11-25

  Toldya: One year ago, BNET noted that Pfizer PFE must have been crazy to sell its consumer products unit to Johnson & Johnson JNJ. The deal included brands such as Nicorette, Zantac and Benadryl. J&J's Q3 earnings report showed that the consumer products unit has done much better than its...

  Tags: Johnson & Johnson, Pfizer Inc., Sales Strategy, Healthcare, Branding, Financial Accounting, Sales, Marketing, Finance, Jim Edwards

• Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash

  BNET - 2009-11-19

  Merck MRK has produced a set of numbers giving a look at the scale of the combined company with Schering-Plough. One surprise: The new company is still just a little bit smaller than the old Pfizer PFE was. The new Merck would have had annual sales $46.7 billion, compared to...

  Tags: Pfizer Inc., Merck & Co. Inc., Sales Strategy, Sales Force Management, Sales, Jim Edwards

• Pfizer's Viagra Shows Signs of Flagging: Sales Down 6%

  BNET - 2009-10-22

  Pfizer's Viagra recorded a 6 percent sales decline, to $466 million worldwide. It wasn't just foreign currency headwinds: The decline was 14 percent in international sales and 1 percent in the U.S. Until now, Viagra has been an almost unstoppable growth machine for Pfizer. The company regularly put the price...

  Tags: Pfizer Inc., Viagra, Sales Strategy, Sales Force Management, Sales, Jim Edwards

• "Pfizer Math" Showed Lyrica Superiority Even Though Studies Never Said That, Rep Claims

  BNET - 2009-09-15

  Pfizer used "Pfizer Math" to persuade doctors that studies showed Lyrica was superior to two anti-seizure drugs, Neurontin and Keppra, when no comparable studies had been done -- and Lyrica was not approved to treat seizures -- according to two former pharmaceutical sales reps. by Jim Edwards

  Tags: Pfizer Inc., Sales Strategy, Sales Force Management, Sales, Jim Edwards

• Pfizer Rep Claims Bextra Pushed on NHL's Blue Jackets

  BNET - 2009-09-11

  Pfizer sales reps allegedly promoted Bextra to the NHL's Columbus Blue Jackets, even though it was only approved for arthritis and menstrual pain -- and not the injuries or surgery that hockey players experience. (The Blue Jackets are an all-male team.) by Jim Edwards

  Tags: Pfizer Inc., NHL, Sales Strategy, Team Management, Sales Force Management, Sales, Management, Jim Edwards

• Pfizer Rep Alleges Viagra Promoted With Unapproved Materials: "Get Those Things Cleaned Up!"

  BNET - 2009-09-08

  Blair Collins, a former Pfizer sales rep who received $2.4 million as one of the whistleblowers in the $2.3 billion Bextra settlement, alleged that reps used unapproved studies and pricing sheets to promote Viagra, among other drugs. by Jim Edwards

  Tags: Pfizer Inc., Pricing Strategy, Viagra, Pfizer Rep, Pricing, Marketing Research, Sales Strategy, Litigation, Marketing, Sales, Business Operations, Jim Edwards

• Pfizer's West Side Story: How "the Sharks" Sold Bextra Off-Label

  BNET - 2009-09-03

  Pfizer had a sales team in Florida that called themselves "the Sharks" as they promoted Bextra off-label, according to documents filed in the one of the cases that led to yesterday's $2.3 billion settlement. by Jim Edwards

  Tags: Pfizer Inc., Sales Strategy, Litigation, Sales, Business Operations, Jim Edwards

• Pfizer Sales Reps Discuss Having Sex With Doctors

  BNET - 2009-07-24

  Sales reps at Pfizer are using a CafePharma bulletin board to discuss whether it is common for their colleagues to sleep with the doctors that they are trying to persuade to write prescriptions. by Jim Edwards

  Tags: Pfizer Inc., Sales Strategy, Sales Force Management, Sales, Jim Edwards

• Pfizer Q2: All But 3 Drugs in Decline; R&D Spend Lowest Since 2007

  BNET - 2009-07-22

  Sales of every single drug sold by Pfizer declined in Q2 2009 except for three: depression pill Lyrica, cancer treatment Sutent and the tiny Revatio franchise. Pfizer blamed foreign currency headwinds as it reported sales of $10.9 billion, down 9 percent; and net income of $2.3 billion, a decline of...

  Tags: R&D, Pfizer Inc., Sales Strategy, Research & Development, Sales Force Management, Sales, Business Operations, Jim Edwards

• Novartis Q2: Generic Sales Decline Is a Warning for Pfizer, Sanofi and Abbott

  BNET - 2009-07-16

  Novartis' Q2 2009 results sound a warning for companies banking on a move into generics to shore up the future for their companies: Novartis' generic unit, Sandoz, performed weakly in both Q2 and the first half of the year, while its branded pharma section grew strongly. by Jim Edwards

  Tags: Pfizer Inc., Novartis AG, Sales Strategy, Banking, Sales, Financial Services, Jim Edwards